Biogen IncBiogen selected Vault CRM, contributing to Veeva's record quarter.
Veeva Systems reported a record second quarter for fiscal 2027, with total revenue of $928 million and non-GAAP operating income of $416 million, both exceeding guidance. The company achieved its best-ever CRM quarter, with two TOP20 biopharma customers, Lilly and Biogen, selecting Vault CRM, bringing the total to 12 of TOP20. Veeva Falcon, its agentic AI product, is generating high customer interest, with early adopters showing promising results and faster implementation. Commercial subscription revenue grew 13% year-over-year, with broad-based strength across CRM, content, data, and Crossix. The company also highlighted progress with its Aspen product, priced at $50 per user per month, and its partnership with IQVIA, which CEO Peter Gassner called one of the best things to happen to Veeva in the past 12 months.
Biogen IncBiogen selected Vault CRM, contributing to Veeva's record quarter.
Eli Lilly and CompanyLilly selected Vault CRM, contributing to Veeva's record quarter.
IQVIA Holdings IncPartnership with IQVIA highlighted as a key positive for Veeva.
Veeva Systems Inc Class ARecord Q2 revenue and operating income exceeded guidance.
Salesforce.com Inc